ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,214Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 939

$863K Total Retail Price of All Prescriptions

Rank: 70 out of 939

583 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 583 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 11,648 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 634 493 1 7
OMEPRAZOLE 529 375 2 5
LEVOTHYROXINE SODIUM 454 362 3 4
SIMVASTATIN 371 274 4 2
ATENOLOL 369 222 5 19
HYDROCODONE-ACETAMINOPHEN 342 201 S3 6 1
GABAPENTIN 342 213 6 11
LISINOPRIL 327 227 8 3
PRAVASTATIN SODIUM 309 188 9 13
CITALOPRAM HBR 282 216 10 15
ZOLPIDEM TARTRATE 281 186 11 20
TRAMADOL HCL 274 208 12 16
AMLODIPINE BESYLATE 255 162 13 6
WARFARIN SODIUM 254 182 14 17
METOPROLOL SUCCINATE 251 186 15 21
MELOXICAM 251 190 15 14
POTASSIUM CHLORIDE 236 161 17 9
METFORMIN HCL 227 155 18 8
CARVEDILOL 226 192 19 25
TRAZODONE HCL 224 133 20 26
NEXIUM 213 104 21 18
AZITHROMYCIN 207 131 22 32
HYDROCHLOROTHIAZIDE 200 142 23 12
METOPROLOL TARTRATE 193 146 24 10
ISOSORBIDE MONONITRATE ER 185 138 25 53
CIPROFLOXACIN HCL 171 139 26 54
ALLOPURINOL 157 146 27 31
DONEPEZIL HCL 142 142 28 30
SERTRALINE HCL 138 87 29 24
CLONIDINE HCL 134 80 30 39
SPIRONOLACTONE 133 97 31 71
TAMSULOSIN HCL 132 97 32 27
ATORVASTATIN CALCIUM 131 96 33 22
LOSARTAN POTASSIUM 131 126 33 29
AMITRIPTYLINE HCL 127 95 R 35 38
CLOPIDOGREL 126 71 36 28
DICLOFENAC SODIUM 126 84 36 93
ESCITALOPRAM OXALATE 125 104 38 61
LYRICA 119 91 39 63
QUETIAPINE FUMARATE 112 107 40 69
LEVOFLOXACIN 111 75 41 86
DOXYCYCLINE HYCLATE 109 65 42 84
PROMETHAZINE HCL 108 37 R 43 68
PANTOPRAZOLE SODIUM 99 54 44 66
PROAIR HFA 98 45 45 41
SUCRALFATE 97 60 46 96
LANTUS 95 39 47 59
CYCLOBENZAPRINE HCL 90 53 R 48 36
NAMENDA 90 90 48 49
BUSPIRONE HCL 87 47 50 123
KLOR-CON M20 86 65 51 90
AMOXICILLIN 86 48 51 92
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 51 53 64
FLUCONAZOLE 82 39 54 140
ROPINIROLE HCL 82 50 54 78
DICYCLOMINE HCL 81 24 56 194
HYDRALAZINE HCL 80 56 57 130
TORSEMIDE 78 57 58 184
TRIAMTERENE-HCTZ 78 52 58 33
SPIRIVA 78 48 58 73
ESTRADIOL 78 20 R 58 79
PAROXETINE HCL 77 61 62 70
DIGOXIN 70 46 63 45
OLANZAPINE 70 50 63 135
GLIPIZIDE 67 42 65 52
LOVASTATIN 67 58 65 46
MIRTAZAPINE 67 44 65 56
ADVAIR DISKUS 67 44 65 60
INSULIN SYRINGE 65 38 69 97
PLAVIX 65 40 69 48
METHOCARBAMOL 62 22 R 71 149
ACTOS 62 44 71 141
MECLIZINE HCL 61 58 73 134
FAMOTIDINE 60 42 74 62
ENALAPRIL MALEATE 59 58 75 65
NITROFURANTOIN MONO-MACRO 59 46 75 180
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 26 77 23
CYMBALTA 56 14 78 44
GLYBURIDE 56 41 R 78 89
TRIAMCINOLONE ACETONIDE 55 37 80 150
AMOX TR-POTASSIUM CLAVULANATE 54 30 81 144
DIOVAN 54 54 81 50
PREDNISONE 54 29 81 42
TRIAMTERENE-HYDROCHLOROTHIAZID 51 33 84 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.